Health Care Delivery

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included the average Affordable Care Act premiums falling 4%; the FDA approving a triple combination treatment for cystic fibrosis; House Republicans releasing part 1 of their healthcare plan.

HHS Secretary Alex Azar said his messaging about the Affordable Care Act (ACA) will be simple if the federal 5th Circuit Court of Appeals, in a decision that is expected any day now, sides with the administration in Texas vs Azar in finding the 2010 landmark health law unconstitutional. “Keep calm and carry on,” he said, as he and CMS Administrator Seema Verma released information about 2020 ACA premiums and health plan choices.

While the number of employers who reported they had self-insured at least one health plan had increased from 1999 to 2016, there was a sharp decrease by 38.7% in 2018, according to research from the Employee Benefit Research Institute.

According to a report from the US Census Bureau, the rising rate of the uninsured appears to be a result of a slump in Medicaid coverage. Health policy experts say the decline reflects efforts by the Trump administration to undermine the Affordable Care Act.

The nation’s community health centers, which serve patients who are largely low income and medically underserved, are facing a repeat of their 2017 funding crisis and are making contingency plans to lay off staff and reduce services, in case Congress does not pass a funding bill by September 30.

The Affordable Care Act’s reductions to Medicare Advantage plan payments were not significantly associated with healthcare access or affordability for enrollees.

An analysis of data from between 2010 and 2017 found that Medicaid expansion promoted HIV testing without increasing HIV risk behavior among nonelderly adults.

Health insurers are planning to expand their Affordable Care Act (ACA) plan offerings next year; a 4-in-1 pill can cut the risk of heart attacks and strokes; employers can see substantial savings with biosimilars if they implement a targeted effort to ecourage biosimilar use.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Health plans on the Affordable Care Act (ACA) exchanges will be required to display quality ratings starting with the 2020 plan year, according to an announcement from CMS, which is expanding the 5-star rating system it uses on Medicare plans to the health insurance exchanges.

This week, the top managed care stories included the Trump administration looking to bar legal immigrants from using public benefits; a study in The American Journal of Managed Care® finding that a law to limit surprise medical bills is working; data on Affordable Care Act enrollment showing the effect of subsidies.

A. Mark Fendrick, MD, professor of Medicine in the School of Medicine, professor of Health Management and Policy in the School of Public Health, and director of the VBID Center at the University of Michigan, discusses how low or no cost sharing for high-value services is particularly important for public health issues or epidemics, such as HIV.

In the event that the Affordable Care Act is overturned, Republic senators are working on a plan to preserve protections for people with pre-existing conditions and allow children to stay on their parents’ health plan until age 26; urinary tract infections (UTI) are increasingly becoming resistant to antibiotics; a study is highlighting how lifestyle choices can impact dementia risk.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

As the fate of the Affordable Care Act (ACA) remains uncertain, 21 million people are at risk of losing their health insurance. In addition to large coverage gains as a result of the ACA, the law resulted in various other sweeping changes to the US healthcare system. Here are 5 things that would be impacted if the ACA is overturned.

This week, the top managed care news included uncertainty surrounding the fate of the Affordable Care Act's individual mandate; a study finding Medicare beneficiaries may be paying more for some generics than brand-name drugs; the Trump administration proposing 5 new payment models to transform kidney disease care.

During oral arguments at the 5th Circuit Court of Appeals, Republican-appointed judges voiced their skepticism over the constitutionality of the individual mandate without the imposed tax while Judge Carolyn Dineen King—appointed by President Jimmy Carter in 1979—did not ask any questions or make any comments about the case.

The 5th Circuit Court of Appeals in New Orleans will hear arguments Tuesday in a lawsuit backed by the Trump administration seeking to reverse the Affordable Care Act (ACA); legislators return from a holiday break to try and reach an agreement on healthcare cost issues; a growing number of Americans in rural areas are turning to telehealth appointments amid hospital closings and a shortage of local primary care doctors, specialists, and other providers.

Individuals in traditional blue-collar jobs were the main beneficiaries of the Affordable Care Act because they were less likely to have employer-based coverage before the law, according to a new study.

A federal appeals court rejected a request to delay next week's hearing on the constitutionality of the Affordable Care Act (ACA); Senator Elizabeth Warren, D-Massachusetts, is calling on former FDA Commissioner Scott Gottlieb, MD, to immediately resign from Pfizer's board of directors; Maine is joining a handful of other states in expanding access to abortion.

Last week, a panel of diverse stakeholders took the stage at the National Comprehensive Cancer Network Policy Summit in Washington, DC, to discuss shifting regulatory action from the federal to the state level, and the possible implications for patient access to high-quality cancer care.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included President Trump issuing an executive order for more healthcare transparency; provisional data indicating that overdose deaths may be falling; the Supreme Court agreeing to hear insurers' Affordable Care Act lawsuit.

The US Supreme Court will decide a case involving 2 insurance companies that claimed they were shorted $12 billion by the federal government for "risk corridor" payments related to the ACA; Missouri's last abortion clinic will stay open until at least Friday after a state circuit court judge extended a preliminary injunction he previously issued; City of Hope will invest $1 billion in a new cancer research center and hospital in Irvine, California.

In a letter to CMS Administrator Seema Verma, Energy and Commerce Committee Chairman Frank Pallone Jr, D-New Jersey, and Ways and Means Committee Chairman Richard E. Neal, D-Massachusetts, have demanded information on the Trump administration’s changes to the federal marketplace, which they say can cause confusion for enrollees, weaken consumer protections, and further compromise the Affordable Care Act (ACA).

The Illinois Senate passed an abortion rights bill; a new study presented last weekend at ASCO 2019 found the Affordable Care Act (ACA) reduced racial disparites in cancer care; Johnson & Johnson has been ordered to pay an additional $300 million in NY talcum powder case.

The Trump administration’s Department of Justice (DOJ) is urging federal courts to strike down the entire Affordable Care Act; a Florida hospital is suing Aetna over the insurer’s Readmission Payment Policy; diabetic amputations disproportionately affect black and Latino individuals.

The Trump administration is planning an Affordable Care Act replacement plan; a drug-resistant fungus has been spreading and causing severe issues for hospitals; protesters gather in Washington, DC, to criticize the FDA's handling of the opioid crisis.

Medicare Advantage (MA) plans will see a 2.53% increase in payments in 2020; the FDA is developing a framework for regulatory oversight of artificial intelligence (AI); a federal court is allowing Wisconsin to withdraw 2 lawsuits from the state challenging the Affordable Care Act (ACA).